ストックスクリーナーアプリを入手
4.6951
1.89%
0.0549
Camp 4 Therapeutics Corp (CAMP) 最新ニュース
CAMP4 Therapeutics Corporation Files Form 8-K for NASDAQ Listing – Company Details and Key Information (March 2026) - Minichart
CAMP4 Appoints Michael MacLean to its Board of Directors - Bitget
Camp4 Therapeutics appoints Michael MacLean to board and expands director compensation - Investing.com
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board - TipRanks
Camp4 Therapeutics appoints Michael MacLean as director, joins Audit and Compensation Committees - TradingView
Camp4 Therapeutics Corp adds veteran leader to accelerate regRNA-based therapy clinical push - Traders Union
New CAMP4 (NASDAQ: CAMP) director MacLean joins, receives option grant - Stock Titan
If You Invested $1,000 in Camp4 Therapeutics Corp. (CAMP) - Stock Titan
Camp4 Therapeutics (CAMP) holder Enavate cuts stake to 4.8% of shares - Stock Titan
EVTL Technical Analysis & Price Forecast - Intellectia AI
Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP) - Seeking Alpha
William Blair Sticks to Its Buy Rating for CAMP4 Therapeutics Corporation (CAMP) - The Globe and Mail
CAMP4 to Participate in Upcoming Investor Conferences - The Manila Times
Biotech firm CAMP4 lines up 3 healthcare investor events - Stock Titan
Cantor Fitzgerald reiterates Overweight on CAMP4 stock, $7 target - Investing.com India
Cantor Fitzgerald reiterates Overweight on CAMP4 stock, $7 target By Investing.com - Investing.com Australia
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress - TipRanks
Camp4 Therapeutics Corp posts full year 2025 financial results and unveils corporate update - Traders Union
Camp4 Therapeutics Earnings Review: Q4 Summary - Benzinga
Camp4 Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewswire
Guidance Update: What is Camp4 Therapeutics Corporations book value per shareEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Regulatory RNA strategy presented for gene expression, Camp4 Therapeutics Corp outlines - Traders Union
Camp4 Therapeutics Corporation announced that it has received $100.167156 million in funding from Janus Henderson Investors, Balyasny Asset Management L.P., Vivo Capital, LLC, Adage Capital Management, L.P., Trails Edge Capital Partners, LLC, SYN - marketscreener.com
Camp4 Therapeutics Corp unveils ASO approach to boost gene expression in SYNGAP1 treatment - Traders Union
Camp4 Therapeutics Corp commits to new therapies for rare and neurological diseases - Traders Union
CAMP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
RBOT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA) - The Globe and Mail
Merger Talk: Whats next for Mondelez International Inc stockQuarterly Profit Review & Verified Chart Pattern Signals - baoquankhu1.vn
Camp4 Therapeutics Corp engages with SYNGAP1 community in Poland family day event - Traders Union
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Immunic (IMUX) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
Cantor Fitzgerald Remains a Buy on CAMP4 Therapeutics Corporation (CAMP) - The Globe and Mail
Market Moves: Can AUUDW maintain its current growth rateEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CNTY PE Ratio & Valuation, Is CNTY Overvalued - Intellectia AI
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
How Camp4 Therapeutics Corporation stock reacts to job market dataMarket Sentiment Report & Weekly Chart Analysis and Guides - mfd.ru
Fed Meeting: Will Camp4 Therapeutics Corporation face regulatory challenges2025 Investor Takeaways & Low Volatility Stock Suggestions - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Moderna (MRNA) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Risk Check: Is TACT undervalued by DCF analysisQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Is Camp4 Therapeutics Corporation stock a buy in volatile marketsJuly 2025 Update & Stepwise Trade Signal Implementation - mfd.ru
Is Camp4 Therapeutics Corporation being accumulated by smart money2025 Market WrapUp & AI Driven Stock Movement Reports - mfd.ru
Can Camp4 Therapeutics Corporation ride the EV waveMarket Trend Review & Free Verified High Yield Trade Plans - mfd.ru
BRID PE Ratio & Valuation, Is BRID Overvalued - Intellectia AI
WRAP PE Ratio & Valuation, Is WRAP Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
SY PE Ratio & Valuation, Is SY Overvalued - Intellectia AI
FMR LLC Increases Stake in Camp4 Therapeutics Corp: A Strategic Move in Biotechnology - GuruFocus
10 Best Online Therapy Platforms In 2026: Tested & Reviewed - Forbes
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Aprea Therapeutics (APRE) - The Globe and Mail
Camp4 Therapeutics shares slide after $30 million equity offering priced - MSN
Downgrade Watch: Can Camp4 Therapeutics Corporation ride the EV waveTrade Analysis Summary & Verified Swing Trading Watchlists - baoquankhu1.vn
Will Camp4 Therapeutics Corporation benefit from rising consumer demand2025 Sector Review & Verified Momentum Stock Alerts - mfd.ru
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Cardiff Oncology (CRDF) - The Globe and Mail
Analysis Recap: Will Camp4 Therapeutics Corporation outperform the market in YEAR2025 Stock Rankings & Weekly High Conviction Ideas - baoquankhu1.vn
Retail Trends: Is CVD Equipment Corporation stock undervalued right nowExit Point & Low Volatility Stock Recommendations - baoquankhu1.vn
Market Outlook: Will Camp4 Therapeutics Corporation stock benefit from M AJuly 2025 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Harbor Wellness Co. Partners with Fit Body Boot Camp for 4-Week Series on Injury Prevention and Proper Form - Sarasota Herald-Tribune
CAMP4 Therapeutics announces $28 million common stock offering - MSN
Signal Recap: Will Camp4 Therapeutics Corporation outperform the market in YEARMarket Growth Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
0.99%
3.03%
大文字化:
|
ボリューム (24 時間):